S'abonner

Effects of established allergen sensitization on immune and airway responses after secondary allergen sensitization - 20/08/11

Doi : 10.1016/j.jaci.2006.04.054 
Katharina Blumchen, MD a, , Kerstin Gerhold, MD a, Marcus Schwede, MD a, Bodo Niggemann, MD a, Anzhela Avagyan, MD a, Anna-Maria Dittrich, MD a, Birgit Wagner, PhD b, Heimo Breiteneder, PhD b, Eckard Hamelmann, MD a
a From the Department of Pediatric Pneumology and Immunology, University Hospital Charité, Berlin 
b Center of Physiology and Pathophysiology, Medical University of Vienna 

Reprint requests: Katharina Blumchen, MD, Department of Pediatric Pneumology and Immunology, University Hospital Charité, Augustenburger Platz 1, 13353 Berlin, Germany.

Berlin, Germany, and Vienna, Austria

Abstract

Background

Spreading of sensitization with clinical manifestation of allergy is often observed in atopic individuals.

Objective

To investigate the effects of an established primary allergen sensitization on immune responses and airway inflammation/reactivity on secondary allergen sensitization and airway challenges in a murine model.

Methods

Balb/c mice were primarily sensitized intraperitoneally with ovalbumin or PBS, followed by systemic sensitization and airway challenges with latex extract as a secondary, unrelated allergen. Purely sham-sensitized animals were included as controls. In a second set of experiments, the primary and secondary allergens were switched.

Results

Sensitization with ovalbumin before sensitization with latex resulted in increased production of total and latex-specific (Hev b 3–specific) IgE and IgG1, and enhanced secretion of TH2-cytokines by spleen mononuclear cells cultured with mitogen compared with single latex-sensitized mice. Furthermore, airway challenges of double-sensitized mice (ovalbumin + latex) with latex caused a significant increase in airway reactivity compared with purely latex-sensitized and challenged animals. These effects were dependent on dosing and timing of the primary sensitization in relation to the secondary sensitization and independent of the primary allergen used.

Conclusion

Primary sensitization boosted systemic TH2 immune responses and enhanced the development of airway reactivity after sensitization and airway challenges with a secondary, unrelated allergen. This effect of consecutive priming was dependent on the strength of the primary sensitization but independent of the allergen used. The results explain the increased susceptibility toward sensitization spreading in atopic individuals.

Clinical implications

Because sensitization spreading is facilitated by primary sensitization, early prevention measurements or immunotherapy should be considered at this stage of monosensitization.

Le texte complet de cet article est disponible en PDF.

Key words : Sensitization, mice, TH1/TH2 cytokines, airway reactivity, airway inflammation

Abbreviations used : AHR, AI, AR, MNC, OVA


Plan


 Supported in part by grants of the German Research Council Ha2162/2-1, NBL3 01ZZ0101, and the Austrian Science Fund grants P12838-GEN and SFB F01802.
Disclosure of potential conflict of interest: K. Blumchen and E. Hamelmann have received grant support from German Research Council Ha2162/2-1, NBL-3 01ZZ0101. The rest of the authors have declared that they have no conflict of interest.


© 2006  American Academy of Allergy, Asthma and Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 118 - N° 3

P. 615-621 - septembre 2006 Retour au numéro
Article précédent Article précédent
  • IL-25 enhances allergic airway inflammation by amplifying a TH2 cell–dependent pathway in mice
  • Tomohiro Tamachi, Yuko Maezawa, Kei Ikeda, Shin-ichiro Kagami, Masahiko Hatano, Yohei Seto, Akira Suto, Kotaro Suzuki, Norihiko Watanabe, Yasushi Saito, Takeshi Tokuhisa, Itsuo Iwamoto, Hiroshi Nakajima
| Article suivant Article suivant
  • Correlation between peripheral blood T-cell profiles and airway inflammation in atopic asthma
  • Toshihiro Shirai, Naoki Inui, Takafumi Suda, Kingo Chida

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.